ALBERT DAVID
Back to Cashflow Statement
|
ALBERT DAVID Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-7.66 Cr | ₹-28 Cr | ₹46 Cr | ₹11 Cr | ₹40 Cr |
What is the latest Cash Flow from Operating Activities ratio of ALBERT DAVID ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2026 | ₹-7.66 Cr |
| Mar2025 | ₹-28 Cr |
| Mar2024 | ₹46 Cr |
| Mar2023 | ₹11 Cr |
| Mar2022 | ₹40 Cr |
How is Cash Flow from Operating Activities of ALBERT DAVID Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-7.66 Cr | Negative | |
| Mar2025 | ₹-28 Cr | Negative | |
| Mar2024 | ₹46 Cr | 332.73 | |
| Mar2023 | ₹11 Cr | -73.98 | |
| Mar2022 | ₹40 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹484.1 Cr | -0% | -4.3% | 8.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,478.0 Cr | -0.2% | -3.2% | 12.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,031.0 Cr | 2% | 5.3% | 57.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,216.0 Cr | -2.4% | -3.1% | 36.4% | Stock Analytics | |
| CIPLA | ₹112,205.0 Cr | 0.6% | -2.2% | -9.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,040.0 Cr | 0.9% | 4% | -7.6% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -0% |
-4.3% |
8.6% |
| SENSEX | -2.8% |
-6.1% |
-11.9% |
You may also like the below Video Courses